Liposome-based approaches to overcome anticancer drug resistance-Reference-Cited by-同舟云学术

Liposome-based approaches to overcome anticancer drug resistance

Published:2003-10 Issue:5 Volume:6 Page:271-279
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Mamot Christoph,Drummond Daryl C.,Hong Keelung,Kirpotin Dmitri B.,Park John W.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference76 articles.

1. Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells;Abe;Int. J. Cancer,1994

2. A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance;Advani;Clin. Cancer Res.,2001

3. In vitro and in vivo liposome-mediated gene transfer leads to human MDR1 expression in mouse bone marrow progenitor cells;Aksentijevich;Hum. Gene Ther.,1996

4. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5′ cholesterol-conjugated phosphorothioate antisense oligonucleotides;Alahari;Mol. Pharmacol.,1996

5. Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large B-cell lymphoma;Aviles;Med. Oncol.,2002

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically driven nanodrug delivery system for targeted lung cancer treatment;Exploration of Medicine;2024-04-25

2. Combination of Physicochemical Tropism and Affinity Moiety Targeting of Lipid Nanoparticles Enhances Organ Targeting;Nano Letters;2024-04-10

3. Enhanced anti-malarial efficacy of mefloquine delivered via cationic liposome in a murine model of experimental cerebral malaria;European Journal of Pharmaceutics and Biopharmaceutics;2024-04

4. A combination of physicochemical tropism and affinity moiety targeting of lipid nanoparticles enhances organ targeting;2023-11-21

5. Development and validation of HPLC method for simultaneous estimation of erlotinib and niclosamide from liposomes optimized by screening design;Journal of Liposome Research;2023-01-02